pharmaphorum

FEBRUARY 26, 2021

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Maria Chatzou Dunford. The landscape for UK SMEs post-COVID.

Vaccines 59

Vaccines Communication Pharmaceutical Companies Pharmaceutical Companies 59

pharmaphorum

DECEMBER 2, 2022

Influencer culture has well and truly taken over the internet, with numerous benefits on offer for pharmaceutical companies in the healthcare influencer space. Company profile: Vinehealth. Viseven’s CEO, Nataliya Andreychuk, details how pharma companies can use modular content to maximise omnichannel marketing.

Communication 52

Communication Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JUNE 6, 2025

Skip to main content Friday 6 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 59

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars 59

pharmaphorum

JULY 7, 2022

Read on to find out about reaching the gold standard of lung cancer screening, the promise of therapeutic cancer vaccines, why diversity is essential in oncology trials, and much more. Realising the promise of cancer vaccines. Immunotherapy: building the fourth pillar of cancer treatment. Read Deep Dive: Oncology in full.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

AUGUST 13, 2020

New York Magazine , the New York Times and The Economist amongst many other news organisations knocked down their paywalls for COVID-19-related coverage to keep readers informed in a rapidly changing and often confusing environment. Think you need to build manufacturing of a vaccine before you know what’s working.

Health and Personal Care Stores 112

Health and Personal Care Stores Vaccines Communication Diabetes 112

pharmaphorum

JUNE 19, 2025

Skip to main content Thursday 19 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Vaccines 52

Vaccines Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JUNE 25, 2025

Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump administration. Robert Barrie June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook RFK Jr has embarked on a mission to reset vaccine regulation and evidence generation in the US.

Vaccines 115

Vaccines Hospitals Packaging Communication 115

Pharmaceutical Technology

JUNE 10, 2025

Robert Barrie and Ross Law June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The removal ACIP members marks the most significant upheaval to the current vaccine landscape under Trump’s administration. Can pharma tariffs “Make America Manufacture Again”? lev radin via Shutterstock. lev radin via Shutterstock.

Vaccines 52

Vaccines Insurance Coverage and Processing Drug Pricing Immunization 52

Pharmaceutical Technology

JUNE 27, 2025

It feels like in the US, pharmaceutical companies are capitalising on people’s frustration and desperation to lose weight.” I don’t understand why medication costs are so much higher in the US compared to Europe, though I’ve noticed prices can vary across European countries too,” said Helena. “It

Drug Pricing 59

Drug Pricing Compounding Packaging Communication 59

Pharmaceutical Technology

JUNE 11, 2025

Katarina Zahedi, pharma analyst at GlobalData, comments: “These investments reflect a growing trend among pharmaceutical companies to bolster domestic operations in response to geopolitical pressures and potential tariffs on imported pharmaceuticals.” Can pharma tariffs “Make America Manufacture Again”?

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Communication Hospitals Packaging 52